CLINICAL_TRIALS
trial_result
· 2021-12-13
Clinical Trial Update: Study of VIR-2218 in Healthy Subjects and Patients With Chronic Hepatitis B [Phase 1, Phase 2]
Summary
Phase 1/2 trial update for VIR-2218 in healthy subjects and chronic hepatitis B patients has completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Vir Biotechnology, Inc. | Conditions: Chronic Hepatitis B | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2021-12-13